Xvivo Perfusion AB

XVIVO.ST · Health Technology · Medical Specialties · SE

59 employees · xvivoperfusion.com

About

Xvivo Perfusion AB is a Swedish medical technology company that specializes in the development of solutions aimed at improving the transplantation of human organs. The company was founded in 1998 by Tetsuzo Akutsu, a renowned Japanese heart surgeon specializing in the treatment of cardiovascular diseases.

Annual results

Reported figures, SEK · revenue down 1.2% in 2025

YearRevenueNet incomeNet marginFree cash flow
2025812M25.0M3.1%—
2024822M172M20.9%—
2023597M91.0M15.2%—
2022415M18.0M4.3%—
2021258M8.0M3.1%—

XVIVO.ST in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Xvivo Perfusion AB are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Xvivo Perfusion AB (XVIVO.ST) — company profile and financials · MarketPulse